IPO - INLIF Ltd

Form Type: 424B4

Filing Date: 2025-01-02

Corporate Action: Ipo

Type: New

Accession Number: 000121390024114202

Filing Summary: INLIF Ltd is conducting an initial public offering (IPO) of its ordinary shares at an offering price of $4.00 per share. The total offering is for 2,000,000 Ordinary Shares, with a potential gross amount of $8,000,000. Prior to this offering, there has been no public market for these shares. The company has received approval from NASDAQ to list under the symbol 'INLF'. A substantial majority of operations will be conducted through the company's operating entity established in China. The prospectus details risks associated with regulatory compliance in China, potential changes to laws affecting foreign investments, and the impact of recent regulatory actions that could materially affect the company's operations and value. There are currently no dividends planned, as the company intends to use future earnings to finance business expansion. Post-offering, directors and significant shareholders will control approximately 86.2% of the shares, influencing company decisions significantly.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2024-12-19

Corporate Action: Ipo

Type: New

Accession Number: 000121390024110533

Filing Summary: INLIF Limited has submitted a request for acceleration of effectiveness for its Registration Statement on Form F-1, allowing it to become effective on December 20, 2024. This request is in accordance with Rule 461 of the Securities Act of 1933. The company aims to ensure adequate distribution of the preliminary prospectus to underwriters and dealers involved in the distribution process. They confirm compliance with Rule 15c2-8 of the Securities Exchange Act of 1934 related to the issuance. The request indicates a significant step towards the company's initial public offering (IPO).

Document Link: View Document

Form Type: DRSLTR

Filing Date: 2024-02-21

Corporate Action: Ipo

Type: Update

Accession Number: 000121390024015894

Filing Summary: INLIF Limited submitted a response to the SEC regarding its Draft Registration Statement on Form F-1. This document is in response to comments received from the SEC staff on January 29, 2024, pertaining to Amendment No. 1 of the registration, which was submitted on January 16, 2024. The company addressed issues concerning regulatory risks posed by the Chinese government that could affect its ability to offer securities abroad. The company emphasized changes made in the prospectus summary regarding operational risks in China, including potential interventions by the PRC government that might materially impact business operations and securities value. INLIF Limited has made revisions to enhance clarity and address concerns raised by the SEC staff concerning these regulatory challenges. Amendment No. 2 accompanies this response letter, aiming to comply with the SEC’s feedback on their disclosures.

Document Link: View Document